Amount Raised
$75 Million
Description
Vesalius Therapeutics, a provider of a platform focused on understanding and treating diseases, has raised $75 million in funding.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech